ACE2 in pulmonary diseases
Author:
Lin Qing,Jia Hongpeng
Reference180 articles.
1. Pulmonary angiotensin-converting enzyme 2 (ACE2) and inflammatory lung disease;Jia;Shock,2016
2. Targeting ACE2 for COVID-19 therapy: opportunities and challenges;Jia;Am J Respir Cell Mol Biol,2021
3. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus;Li;Nature,2003
4. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor;Hoffmann;Cell,2020
5. Distribution of ACE2, CD147, CD26, and other SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID-19 risk factors;Radzikowska;Allergy,2020